Crystallographic analysis of triclosan bound to enoyl reductase

被引:88
作者
Roujeinikova, A
Levy, CW
Rowsell, S
Sedelnikova, S
Baker, PJ
Minshull, CA
Mistry, A
Colls, JG
Camble, R
Stuitje, AR
Slabas, AR
Rafferty, JB
Pauptit, RA
Viner, R
Rice, DW [1 ]
机构
[1] Univ Sheffield, Krebs Inst Biomol Res, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England
[2] AstraZeneca, Macclesfield SK10 4TG, Cheshire, England
[3] Vrije Univ Amsterdam, Bioctr, Inst Mol Biol Studies, Dept Genet, NL-1081 HV Amsterdam, Netherlands
[4] Univ Durham, Dept Biol Sci, Durham DH1 3LE, England
[5] Zeneca Agrochem, Jealotts Hill Res Stn, Bracknell RG12 6EY, Berks, England
[6] Parke Davis Pharmaceut Biomol Struct & Drug Desig, Ann Arbor, MI 48105 USA
基金
英国惠康基金;
关键词
triclosan; inhibitor binding; enoyl reductase; crystal structure; resistance;
D O I
10.1006/jmbi.1999.3240
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Molecular genetic studies with strains of Escherichia coli resistant to triclosan, an ingredient of many anti-bacterial household goods, have suggested that this compound works by acting as an inhibitor of enoyl reductase (ENR) and thereby blocking Lipid biosynthesis. We present structural analyses correlated with inhibition data, on the complexes of E. coli and Brassica napus ENR with triclosan and NAD(+) which reveal how triclosan acts as a site-directed, picomolar inhibitor of the enzyme by mimicking its natural substrate. Elements of both the protein and the nucleotide cofactor play important roles in triclosan recognition, providing an explanation for the factors controlling its tight binding to the enzyme and for the emergence of triclosan resistance. (C) 1999 Academic Press.
引用
收藏
页码:527 / 535
页数:9
相关论文
共 35 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   The X-ray structure of Escherichia coli enoyl reductase with bound NAD+ at 2.1 Å resolution [J].
Baldock, C ;
Rafferty, JB ;
Stuitje, AR ;
Slabas, AR ;
Rice, DW .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 284 (05) :1529-1546
[3]   A mechanism of drug action revealed by structural studies of enoyl reductase [J].
Baldock, C ;
Rafferty, JB ;
Sedelnikova, SE ;
Baker, PJ ;
Stuitje, AR ;
Slabas, AR ;
Hawkes, TR ;
Rice, DW .
SCIENCE, 1996, 274 (5295) :2107-2110
[4]   INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS [J].
BANERJEE, A ;
DUBNAU, E ;
QUEMARD, A ;
BALASUBRAMANIAN, V ;
UM, KS ;
WILSON, T ;
COLLINS, D ;
DELISLE, G ;
JACOBS, WR .
SCIENCE, 1994, 263 (5144) :227-230
[5]  
BERGLER H, 1994, J BIOL CHEM, V269, P5493
[6]   Triclosan: Applications and safety [J].
Bhargava, HN ;
Leonard, PA .
AMERICAN JOURNAL OF INFECTION CONTROL, 1996, 24 (03) :209-218
[7]  
BOER GJ, 1999, MOL MICROBIOL, V31, P443
[8]   CRYSTALLOGRAPHIC R-FACTOR REFINEMENT BY MOLECULAR-DYNAMICS [J].
BRUNGER, AT ;
KURIYAN, J ;
KARPLUS, M .
SCIENCE, 1987, 235 (4787) :458-460
[9]   FROM CRYSTAL STATICS TO CHEMICAL-DYNAMICS [J].
BURGI, HB ;
DUNITZ, JD .
ACCOUNTS OF CHEMICAL RESEARCH, 1983, 16 (05) :153-161
[10]  
*FDC REP, 1998, TAN SHEET, P14